Article
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity # †
19 Mar 2009
Abstract excerpt
UNLABELLED: The risk of hemochromatosis-related morbidity is unknown among HFE compound heterozygotes (C282Y/H63D). We used a prospective population-based cohort study to estimate the prevalence of elevated iron indices and hemochromatosis-related morbidity for compound heterozygotes. In all, 31,192 subjects of northern European descent were genotyped for HFE C282Y and H63D. An HFE-genotype stratified random...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
